These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34663988)

  • 1. Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain.
    Keiser MS; Ranum PT; Yrigollen CM; Carrell EM; Smith GR; Muehlmatt AL; Chen YH; Stein JM; Wolf RL; Radaelli E; Lucas TJ; Gonzalez-Alegre P; Davidson BL
    Nat Med; 2021 Nov; 27(11):1982-1989. PubMed ID: 34663988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
    Keiser MS; Kordower JH; Gonzalez-Alegre P; Davidson BL
    Brain; 2015 Dec; 138(Pt 12):3555-66. PubMed ID: 26490326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi prevents and reverses phenotypes induced by mutant human ataxin-1.
    Keiser MS; Monteys AM; Corbau R; Gonzalez-Alegre P; Davidson BL
    Ann Neurol; 2016 Nov; 80(5):754-765. PubMed ID: 27686464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.
    Keiser MS; Geoghegan JC; Boudreau RL; Lennox KA; Davidson BL
    Neurobiol Dis; 2013 Aug; 56():6-13. PubMed ID: 23583610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of AAV Vectors for Delivery of RNAi.
    Borel F; Mueller C
    Methods Mol Biol; 2019; 1950():3-18. PubMed ID: 30783965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.
    Keiser MS; Boudreau RL; Davidson BL
    Mol Ther; 2014 Mar; 22(3):588-595. PubMed ID: 24419082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.
    Borel F; Kay MA; Mueller C
    Mol Ther; 2014 Apr; 22(4):692-701. PubMed ID: 24352214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
    Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
    Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
    Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of shRNA and miRNA for Delivery to the CNS.
    Toro Cabrera G; Mueller C
    Methods Mol Biol; 2016; 1382():67-80. PubMed ID: 26611579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
    Heister T; Heid I; Ackermann M; Fraefel C
    J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Small RNA-Seq of Adeno-Associated Virus (AAV)-Infected Human Cells Detects Patterns of Novel, Non-Coding AAV RNAs in the Absence of Cellular miRNA Regulation.
    Stutika C; Mietzsch M; Gogol-Döring A; Weger S; Sohn M; Chen W; Heilbronn R
    PLoS One; 2016; 11(9):e0161454. PubMed ID: 27611072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
    Miyazaki Y; Du X; Muramatsu S; Gomez CM
    Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-Associated Virus Vectors Encoding Short-Hairpin RNA.
    Enomoto M; Hirai T; Kaburagi H; Yokota T
    Methods Mol Biol; 2016; 1364():277-90. PubMed ID: 26472458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems.
    Chen X; Ravindra Kumar S; Adams CD; Yang D; Wang T; Wolfe DA; Arokiaraj CM; Ngo V; Campos LJ; Griffiths JA; Ichiki T; Mazmanian SK; Osborne PB; Keast JR; Miller CT; Fox AS; Chiu IM; Gradinaru V
    Neuron; 2022 Jul; 110(14):2242-2257.e6. PubMed ID: 35643078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective and Accurate Gene Silencing by a Recombinant AAV-Compatible MicroRNA Scaffold.
    Xie J; Tai PWL; Brown A; Gong S; Zhu S; Wang Y; Li C; Colpan C; Su Q; He R; Ma H; Li J; Ye H; Ko J; Zamore PD; Gao G
    Mol Ther; 2020 Feb; 28(2):422-430. PubMed ID: 31843447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.
    Aurnhammer C; Haase M; Muether N; Hausl M; Rauschhuber C; Huber I; Nitschko H; Busch U; Sing A; Ehrhardt A; Baiker A
    Hum Gene Ther Methods; 2012 Feb; 23(1):18-28. PubMed ID: 22428977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
    Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
    Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.